Search Results

240 results for ptie

17 Stocks to Play Space Race 2.0

A second space stocks race is already underway, and it’s shaping up to be one of the most powerful industrial trends of the next two…

CPI Data Doesn’t Derail Rate Cut Hopes

Why Wall Street’s AI Bet May Be Dead Wrong

While Wall Street and Silicon Valley obsess over when ChatGPT-5 will launch—or how many exaflops xAI is hoarding—they’re missing the real earthquake: small language models…

BMNR: The Big Ethereum Opportunity Wall Street Can’t Ignore

ChatGPT Was Just the Beginning. The Real Shift Starts Now.

The smart money is rotating into the AI robotics stack. And if history is any guide, this trade could be the biggest yet…

Earnings Season Makes It Clear: AI Is the Only Game in Town

Earnings results from Microsoft, Alphabet, Meta, and others show explosive growth. Here’s how AI is rewriting Wall Street’s playbook.

Are Semiconductors a “Sell” After Trump Tariffs?

Inside the AI Megatrends Driving Today’s Stock Market Gains

The AI boom is accelerating – from Tesla’s humanoid bot to rising quantum and nuclear plays. Here’s where smart money is heading now.

Alphabet and ServiceNow Smash Earnings: Why the Best Is Yet to Come

Q2 earnings reinforce that AI-driven companies are pulling far ahead of the pack, with no sign of slowing anytime soon.

Tariff Panic Is Back – But Here’s Why I’m Not Worried

Last week marked a critical moment in one of the biggest market stories of the year… Yes, I’m talking about tariffs again, folks.

Beyond GPUs: Why Neuromorphic Chips Could Power the Future of AI

Neuromorphic chips mimic the brain to deliver faster, lower-power AI. Explore where this next-gen tech could make the biggest impact.

Copper at $5.50 Could Signal the Start of an AI Metals Explosion

Dr. Copper is making a new prediction. It’s one that spells great news for the $1 trillion AI industry… and especially a small subsector you don’t…

10 Stocks to Sell Before the Second Half of the Year

In today’s Market 360, I want to share 10 stocks my system says you should consider parting ways with now. These aren’t the kind of…

The Setup Before the Spike — Inside the Week’s Biggest Trades

Big moves start quietly — sometimes weeks or even months in advance. And the people who know how to follow the money — real money…

Earnings Growth Hamper Pain Therapeutics (PTIE) Rating

The current recommendation of Hold for Pain Therapeutics Inc (NASDAQ:PTIE) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier’s investing approach.…

Pain Therapeutics Jumps 50% on Promising Remoxy Study (PTIE)

Pain Therapeutics (PTIE) stock is soaring Tuesday after its REMOXY study shows the drug could deter prescription painkiller abuse.

This Inevitable Trend Soared a Quick 50%…This Morning

Remoxy’s Rejection Drives PTIE Stock 70% Lower

The FDA Advisory Committee’s decision to vote against Remoxy has left PTIE stock in the dumps because the firm has very few other options coming…

3 Stocks to Watch on Monday: Twitter Inc (TWTR), Walt Disney Co (DIS) and Pain Therapeutics, Inc. (PTIE)

Twitter (TWTR) gets a downgrade amid buyout rumors, Disney (DIS) is lowered too and Pain Therapeutics (PTIE) suffers a huge setback.

Biotech Movers: Enzo Biochem Rockets on Patent Ruling

ENZ is awarded $48.6 million in penalties, and more could be coming. Plus: Why Abiomed, Pain Therapeutics, Impax and BioCryst all took big falls.

Pain Therapeutics Stock Skyrockets on Alzheimer’s Grant

Pain Therapeutics (PTIE) stock was soaring Wednesday on news of a grant to study Alzheimer’s disease from the National Institutes of Health.

3 Pharmaceuticals Stocks to Sell Now

The overall ratings of 3 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

6 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…

6 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…

1 – 10 of 240 results